drugset / Trial / NCT00628719

Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis

NCT00628719

Phase 3 Completed 400 enrolled Banaras Hindu University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this trial is to evaluate the efficacy of single dose amphotericin B in the treatment of Visceral Leishmaniasis (VL) in India.

Timeline

Start
2008-02
Primary completion
2008-08
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Amphotericin B Unknown 10 mg/kg Other
Comparator amphotericin B deoxycholate Unknown 1 mg/kg Other